Parnell Pharmaceuticals Holdings Ltd [●] Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • April 29th, 2016 • Parnell Pharmaceuticals Holdings LTD • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of January 23, 2014 among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, and PARNELL, INC. as Borrowers, THE SUBSIDIARIES OF THE BORROWERS, as Guarantors, THE LENDERS PARTY HERETO, as Lenders, and SWK FUNDING LLC, as Agent, Sole...Credit Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
This Credit Agreement (“Agreement”) dated as of January 23, 2014, among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, a proprietary company limited by shares incorporated under the laws of Australia (“Australian Borrower”), PARNELL, INC., a corporation incorporated under the laws of the state of Delaware, United States of America (“U.S. Borrower”, and together with Australian Borrower, each individually, a “Borrower”, and collectively, the “Borrowers”), the Guarantors (as defined herein), the financial institutions party hereto from time to time as Lenders (“Lenders”) and SWK Funding LLC (in its individual capacity, “SWK”), as Agent for all Lenders.
SUPPLY AGREEMENT ON GONADORELIN ACETATEConfidential Treatment • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
ContractSupply Agreement • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • New York
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
CREDIT AGREEMENT dated as of January 23, 2014 among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, and PARNELL, INC. as Borrowers, THE SUBSIDIARIES OF THE BORROWERS, as Guarantors, THE LENDERS PARTY HERETO, as Lenders, and SWK FUNDING LLC, as Agent, Sole...Credit Agreement • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
This Credit Agreement (“Agreement”) dated as of January 23, 2014, among PARNELL PHARMACEUTICALS HOLDINGS PTY LTD, a proprietary company limited by shares incorporated under the laws of Australia (“Australian Borrower”), PARNELL, INC., a corporation incorporated under the laws of the state of Delaware, United States of America (“U.S. Borrower”, and together with Australian Borrower, each individually, a “Borrower”, and collectively, the “Borrowers”), the Guarantors (as defined herein), the financial institutions party hereto from time to time as Lenders (“Lenders”) and SWK Funding LLC (in its individual capacity, “SWK”), as Agent for all Lenders.
LICENCE AGREEMENT CIMTECH PTY LIMITED and PARNELL TECHNOLOGIES PTY LTD PageSub-License Agreement • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
BETWEEN CIMTECH PTY LIMITED ACN 127 621 345 of Suite 3, National Innovation Centre, Australian Technology Park, 4 Cornwallis St, Eveleigh, New South Wales, Australia (“CIMTECH”)
Parnell Pharmaceuticals Holdings Ltd Award AgreementAward Agreement • May 7th, 2015 • Parnell Pharmaceuticals Holdings LTD • Pharmaceutical preparations • New South Wales
THIS AWARD AGREEMENT (this “Agreement”), effective as of the Date of Award set forth above, represents an award of the options and units set forth above (the “Equity Award”) by Parnell Pharmaceuticals Holdings Ltd, an Australian company limited by shares (the “Company”), to the Participant named above, pursuant to the provisions of the Plan.
DISTRIBUTION AND SUPPLY AGREEMENT PARNELL NORTH AMERICA PTY LTDDistribution and Supply Agreement • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • New South Wales
ContractSupply Agreement • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • New York
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
Distribution and Supply AgreementConfidential Treatment • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
This is Amendment number 1 to the agreement between Eli Lilly and Company and Parnell Europe Pty Ltd. titled Distribution and Supply Agreement and dated February 9, 2011 (“Agreement”). By this amendment, entered into on this 2nd day of December, 2011, both parties agree as follows:
LEASE PARNELL, INC. AND UCM/SREP-CORPORATE WOODS, LLCOffice Lease • May 19th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
Supply Agreement for Pentosan Polysufate Active Pharmaceutical Ingredient Between Parnell Manufacturing Pty Ltd (ABN 46 138 251 582) and IDT Australia Limited (ABN 66 066 522 970) Effective Date: 3 December 2013Confidential Treatment • June 10th, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • Victoria
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 3rd, 2016 • Parnell Pharmaceuticals Holdings LTD • Pharmaceutical preparations • Illinois
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 23rd day of February, 2016 by and between PARNELL PHARMACEUTICALS HOLDINGS LTD, a public company limited by shares incorporated under the laws of Australia (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
OFFICE LEASEOffice Lease • September 15th, 2014 • Parnell Pharmaceuticals Holdings LTD • Pharmaceutical preparations
DISTRIBUTION AND SUPPLY AGREEMENT PARNELL EUROPE PTY LTD ABN A2 138 251 56A and ELANCO, a division of ELI LILLY and COMPANYDistribution and Supply Agreement • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations
PARNELL EUROPE PTY LTD ABN 42 138 251 564 a company, organised under the laws of Australia, with registered office at Unit 4, 476 Gardeners Road, Alexandria, New South Wales, Australia Represented by Mr. R JOSEPH, Chief Executive Officer, Hereinafter referred to as Parnell.
Supply Agreement for Pentosan Polysufate Active Pharmaceutical Ingredient Between Parnell Manufacturing Pty Ltd (ABN 46 138 251 582) and IDT Australia Limited (ABN 66 066 522 970) Effective Date: 3 December 2013Confidential Treatment • May 1st, 2014 • Parnell Pharmaceuticals Holdings Pty LTD • Pharmaceutical preparations • Victoria
Parnell Manufacturing Pty Ltd (ABN; 46 138 251 582), a corporation duly incorporated under the laws of New South Wales having an office at; 4 Century Estate, 476 Gardner’s Road, Alexandria, NSW 2015 (“Customer”)
